AMNEAL PHARMACEUTICALS, INC. Payments for Repurchase of Redeemable Noncontrolling Interest
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Payments for Repurchase of Redeemable Noncontrolling Interest of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest · last filed 2025-02-28
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2023-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2023-09-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2023-06-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2024 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2022 was $1.72M.
- AMNEAL PHARMACEUTICALS, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2021 was $0.00.
| Period end | Payments for Repurchase of Redeemable Noncontrolling Interest 3 month | Payments for Repurchase of Redeemable Noncontrolling Interest 3 month as first filed | Payments for Repurchase of Redeemable Noncontrolling Interest 6 month | Payments for Repurchase of Redeemable Noncontrolling Interest 9 month | Payments for Repurchase of Redeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $1.72M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $1.72M 10-Q · filed 2023-11-09 | $1.72M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.72M 10-Q · filed 2023-08-08 | $1.72M derived: sum of 3 quarters · filed 2024-03-14 | $1.72M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | $1.72M 10-Q · filed 2023-05-09 | $1.72M derived: sum of 2 quarters · filed 2024-03-14 | $1.72M derived: sum of 3 quarters · filed 2024-03-14 | $1.72M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-03 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $11.78M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $11.78M 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $12.00M 10-K · filed 2020-03-02 | $11.80M 10-Q · filed 2018-11-07 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |